Background illustration for clinical trials search

Paid Clinical Trials Arlington

Discover 1,917 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

for
Locally Advanced Breast Cancer, Unresectable Breast Carcinoma,
Location: Dallas TX, San Antonio TX, Kansas City MO, St Louis MO,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06827236

Phase1, Phase2, Recruiting

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

for
Aortic Stenosis, Calcific, Aortic Valve Stenosis
Location: Dallas TX, Plano TX, Austin TX, Houston TX, Tulsa OK,
Sponsor: Edwards Lifesciences

Sex: All

Age: 65+

Code: NCT04889872

Recruiting

Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System

for
Cancer, Cancer Central Nervous System, Cancer Thoracic,
Location: Dallas TX, Pittsburgh PA, Duarte CA, Palo Alto CA,
Sponsor: RefleXion Medical

Sex: All

Age: 0+

Code: NCT05406167

Recruiting

Onyx™ Liquid Embolic IDE Clinical Study

for
Peripheral Arterial Hemorrhage, Trauma, GI Bleed, Ulcer,
Location: Dallas TX, Houston TX, Omaha NE, Nashville TN,
Sponsor: Medtronic Endovascular

Sex: All

Age: 22+

Code: NCT06742801

Recruiting

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

for
Multiple Sclerosis
Location: Dallas TX, Plano TX, Oklahoma City OK, El Paso TX,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 18 - 55

Code: NCT06735248

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

for
Neoplasms, Child, Adolescent
Location: Dallas TX, Houston TX, Kansas City MO, Denver CO,
Sponsor: Eli Lilly and Company

Sex: All

Age: 1 - 39

Code: NCT05999994

Phase2, Recruiting

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

for
Pulmonary Invasive Fungal Infections,
Location: Dallas TX, Austin TX, Houston TX, Little Rock AR,
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 0 - 21

Code: NCT03827694

Recruiting

Once Weekly Infant Corticosteroid Trial for DMD

for
Duchenne Muscular Dystrophy
Location: Dallas TX, Chicago IL, Cincinnati OH, Columbus OH
Sponsor: Anne M. Connolly

Sex: Male

Age: 0 - 2

Code: NCT05412394

Recruiting

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

for
Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS),
Location: Dallas TX, Houston TX, Denver CO, Chicago IL,
Sponsor: Institut de Recherches Internationales Servier

Sex: All

Age: 18+

Code: NCT06465953

Phase3, Recruiting

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

for
Relapsed/Refractory Multiple Myeloma
Location: Dallas TX, Austin TX, Houston TX, Birmingham AL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05850234

Phase1, Phase2, Recruiting

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumors
Location: Dallas TX, Austin TX, Nashville TN, Atlanta GA,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05914116

Phase1, Phase2, Recruiting

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

for
Severe Asthma
Location: Dallas TX, Lewisville TX, McKinney TX, Kerrville TX,
Sponsor: Generate Biomedicines

Sex: All

Age: 12 - 70+

Code: NCT07276724

Phase3, Recruiting

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

for
Small-cell Lung Cancer
Location: Dallas TX, Austin TX, Odessa TX, Columbia MO,
Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT07218146

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

for
Secondary Progressive Multiple Sclerosis (SPMS)
Location: Dallas TX, Plano TX, Cordova TN, Kansas City KS,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07225504

Phase3, Recruiting

DESTINY-PANTUMOUR04

for
Adenocarcinoma (NOS), Anal Cancer, Bladder Cancer,
Location: Dallas TX, Topeka KS, Birmingham AL, Nashville TN,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07124000

Recruiting

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Dallas TX, Lubbock TX, Jefferson LA, St Louis MO,
Sponsor: Arcus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07011719

Phase3, Recruiting

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

for
Lupus Nephritis
Location: Dallas TX, Plano TX, Houston TX, Lake Charles LA,
Sponsor: Aurinia Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07611214

Recruiting

Observational Study Protocol: LIVER-R

for
Hepatobiliary Cancers
Location: Dallas TX, Temple TX, Baton Rouge LA, Osage Beach MO,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06252753

Recruiting

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

for
Delayed Graft Function, DGF, Kidney Transplant
Location: Dallas TX, Houston TX, Fairway KS, Kenner LA,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06830798

Phase3, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Dallas TX, McKinney TX, Houston TX, Cypress TX,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase3, Recruiting